Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland 21287


Purpose:

The purpose of this study is to determine the relationship between ITI-007 dose, plasma levels and brain receptor occupancy in patients with stable schizophrenia.


Criteria:

Inclusion Criteria: - Patients with schizophrenia who are drug-free with regard to their antipsychotic medication - In clinical remission and free from acute exacerbation of their psychosis - In good health Exclusion Criteria: - Clinically significant medical conditions considered inappropriate for trial participation


NCT ID:

NCT02288845


Primary Contact:

Study Director
Kimberly Vanover, Ph.D.
Intra-Cellular Therapies, Inc. (ITI)


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland 21287
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.